Pediatric Psychopharmacology for Primary Care

Riddle, Mark A.

ISBN 10: 1581102755 / ISBN 13: 9781581102758

Editore: American Academy of Pediatrics, 2015

Riguardo questo articolo

Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less 0.85. Codice articolo G1581102755I2N00

Dati bibliografici

Titolo: Pediatric Psychopharmacology for Primary Care

Casa editrice: American Academy of Pediatrics

Data di pubblicazione: 2015

Legatura: Paperback

Condizione: As New

Condizione sovraccoperta: No Jacket

Descrizione articolo

Riassunto:

Confidently prescribe, monitor, and manage medications for childhood mental health disorders.

This game-changing resource from the American Academy of Pediatrics (AAP) arms you with a unique strategic approach - plus practice-tested, condition-specific treatment recommendations. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. 

Free bonus digital tool!  Get instant answers on specific conditions and medications from your desktop or mobile device!

Evidence-based conceptual framework
A clear, straightforward methodology - based on current research and clinical experience - defines discrete levels of psychotropic agents and spells out level-specific roles and responsibilities.

Group 1:Medications FDA-approved for youth for ADHD, anxiety, and depression - disorders for which pediatric primary care providers commonly initiate treatment and assume prescribing and monitoring responsibilities.
Administration and management information for each drug agent includes:

• Rationale for use
• Evidence supporting efficacy and safety
• Initial dosing and subsequent adjustments
• Measuring therapeutic success
• When to consult or refer

Group 2: Medications FDA-approved for youth, typically prescribed by specialists but often monitored in the primary care setting:  antipsychotics, mood stabilizers, antidepressants, anxiolytics, and sleep aids. To support primary care clinician's collaborative role, usage rationales, efficacy data, and adverse effect profiles are specified for all of these agents.

Group 3: Medications not FDA-approved for youth that primary care clinicians will likely encounter. To support primary care clinician's collaborative role, efficacy data and adverse effect profiles are specified for these agents.

Proven, practice-focused guidance
Hands-on help spanning the therapeutic process:

• Assessing for common disorders
• Assessing for psychiatric comorbidities
• Identifying medication needs
• Informed consent
• Monitoring patient progress
• Managing side effects
• Managing multiple medications
• Stopping or changing medications

Informazioni sull?autore:

Mark A. Riddle, M.D. is Professor of Psychiatry and Pediatrics and former Director of the Division of Child and Adolescent Psychiatry at the Johns Hopkins University School of Medicine. His research, teaching and clinical practice focuses on pediatric psychopharmacology, particularly the efficacy and safety of psychotropic medications in children and adolescents. Dr. Riddle serves as a member of the National Institute of Child Health and Human Development-sponsored Data and Safety Monitoring Board for the Best Pharmaceuticals for Children Act. His clinical research and publications include pivotal studies of all of the major groups of medications prescribed to treat psychiatric disorders in children and adolescents.